# AZD8683 Single Ascending Dose Study

> **NCT00979849** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 130 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AZD8683
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00979849
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979849, "AZD8683 Single Ascending Dose Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00979849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*